Arbutus Biopharma ABUS
NASDAQ ABUS
$4.69 -0.17 (-3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Non-Current Debt (2016 - 2017)

Updated

Arbutus Biopharma (ABUS) reported Non-Current Debt of $12 million for Q4 2017, unchanged from $12 million a year earlier and unchanged from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Non-Current Debt (2016 - 2017) Analysis & Trends

Dating back to Q4 2016, Arbutus Biopharma's Non-Current Debt record includes 5 quarters.

  • By year, Non-Current Debt came in at $12 million in FY2016.
  • Per Business Quant data, the three quarters before Q4 2017 came in at $12 million (Q3 2017), $12 million (Q2 2017) and $12 million (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Arbutus Biopharma 960.50 Mn 587.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 12.00 Mn
Sep 30, 2017 12.00 Mn
Jun 30, 2017 12.00 Mn
Mar 31, 2017 12.00 Mn
Dec 31, 2016 12.00 Mn
API Access

Arbutus Biopharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ABUS&period=max&api_key=YOUR_API_KEY